Sanofi, FR0000120578

Thomapyrin pain relief tablets explained for US readers

19.05.2026 - 16:30:57 | ad-hoc-news.de

Thomapyrin pain relief tablets combine well-known active ingredients to treat headaches and migraines. Here is how the product works, how it is used, and what US consumers should know.

Sanofi, FR0000120578
Sanofi, FR0000120578

Thomapyrin pain relief tablets are an over-the-counter combination medicine widely used in Germany for headaches and migraine attacks, according to the German patient information from the manufacturer A. Nattermann & Cie GmbH, accessed via Sanofi Germany on 03/15/2025Sanofi, 03/15/2025Thomapyrin, 03/15/2025.

Updated: 05/19/2026 | Reading time: approx. 7 minutes

By the AD HOC NEWS editorial team - specialized in product-led market coverage.

At a Glance

  • Product: Thomapyrin pain relief tablets
  • Category: Over-the-counter analgesic
  • Brand/Manufacturer: Thomapyrin / A. Nattermann & Cie GmbH (Sanofi)
  • Main Use Cases: Headache and migraine relief
  • Availability: Nonprescription in Germany and parts of Europe
  • Key Markets: Germany and selected European countries

What Thomapyrin pain relief tablets are and how they work

Thomapyrin is a line of oral pain relief tablets that combines acetylsalicylic acid, paracetamol, and caffeine in certain variants, as described in German product information for Thomapyrin INTENSIVThomapyrin, 03/15/2025Sanofi, 03/15/2025.

The combination of these active substances is designed to address headache mechanisms in different ways, according to clinical explanations cited by the brand on its German consumer siteThomapyrin, 03/15/2025Sanofi, 03/15/2025.

Thomapyrin tablets are typically swallowed with water and are offered in variants targeted at classic headaches, tension headaches, and migraine, based on the German portfolio overview for Thomapyrin Classic, INTENSIV, and TENSION DUOThomapyrin, 03/15/2025Sanofi, 03/15/2025.

Key ingredients in Thomapyrin variants

Thomapyrin INTENSIV and some related products in Germany combine acetylsalicylic acid, paracetamol, and caffeine, according to the German package leaflet and official brand siteThomapyrin, 03/15/2025Sanofi, 03/15/2025.

Other Thomapyrin formats, such as Thomapyrin Classic and Thomapyrin TENSION DUO, are positioned for different headache profiles and may vary in exact active substances, per the German pharmacy descriptions and brand explanationsThomapyrin, 03/15/2025DocMorris, 03/01/2025.

Why Thomapyrin matters for consumers and industry

In Germany, Thomapyrin is positioned as a nonprescription option for tension headaches and migraine headaches with or without aura in adults and adolescents, as described in the German summary of product characteristicsThomapyrin, 03/15/2025Sanofi, 03/15/2025.

The presence of a fixed-dose combination can offer convenience for consumers dealing with episodic headaches, since they do not need to combine separate medicines themselves, as noted by consumer-oriented explanations on the brand site and German pharmacy portalsThomapyrin, 02/20/2025Apotheken Umschau, 03/10/2025.

For the pharmaceutical industry, Thomapyrin demonstrates how established pain ingredients can be repackaged and marketed in targeted combinations for specific headache types, according to overviews of the nonprescription analgesic market in GermanyApotheke Adhoc, 01/30/2025Pharmazeutische Zeitung, 02/05/2025.

Relevance for US consumers

Thomapyrin itself is not widely marketed as a branded product in US pharmacies, but the same active substances, such as aspirin, acetaminophen, and caffeine, are commonly used in US over-the-counter headache combinations, as described by the US Food and Drug Administration and US consumer health guidesFDA, 01/15/2025Mayo Clinic, 02/01/2025.

This makes Thomapyrin an interesting reference product for US readers who may encounter it while traveling or comparing international headache brands, since its structure resembles combination analgesics available in the United StatesFDA, 01/15/2025Harvard Health, 03/05/2025.

Thomapyrin in the US and global market

Thomapyrin is mainly sold in Germany and some other European countries as an over-the-counter pain relief tablet, according to the product pages and European pharmacy listingsThomapyrin, 03/15/2025DocMorris, 03/01/2025.

In the United States, similar combination pain products are regulated as nonprescription drugs by the FDA and must comply with monograph requirements for active ingredients such as acetaminophen and aspirin, as explained in FDA over-the-counter drug guidanceFDA, 01/15/2025FDA, 02/10/2025.

For travelers, understanding that Thomapyrin is a combination of recognizable pain ingredients can help them discuss options with healthcare professionals if they experience intense headaches while abroad in EuropeCDC, 01/20/2025FDA, 01/15/2025.

  • Thomapyrin tablets are used for headache and migraine relief in adults and adolescents in Germany.
  • The product combines well-known analgesic and stimulant ingredients in certain variants.
  • US consumers see similar combinations in domestic over-the-counter brands.
  • Thomapyrin is sold without a prescription in Germany and parts of Europe.

Official Source

The official company page offers the most direct source on Thomapyrin pain relief tablets.

Visit Company Page

Frequently Asked Questions About Thomapyrin pain relief tablets

Is Thomapyrin available in US pharmacies?
Thomapyrin as a brand is mainly distributed in Germany and some European markets; US pharmacies instead offer comparable combination analgesics with similar active substances, according to regulatory and consumer sourcesFDA, 01/15/2025Mayo Clinic, 02/01/2025.

For which headaches is Thomapyrin used in Germany?
German product information describes Thomapyrin variants being used for tension headaches and migraine attacks with or without aura in adults and certain adolescents, subject to local labeling and guidanceThomapyrin, 03/15/2025Sanofi, 03/15/2025.

Can US travelers use Thomapyrin when visiting Europe?
US travelers who consider using Thomapyrin during a trip should review the local package leaflet and consult a healthcare professional, since regulations and recommended use may differ from US over-the-counter productsCDC, 01/20/2025FDA, 02/10/2025.

Continue Reading

More reports and developments on Thomapyrin pain relief tablets are available in the overview.

More on Thomapyrin pain relief tablets

The Thomapyrin brand is owned and marketed in Germany by A. Nattermann & Cie GmbH, which belongs to the global healthcare company Sanofi, according to Sanofi Germany company informationSanofi, 03/15/2025Sanofi, 03/10/2025.

Sanofi is listed on Euronext Paris under the ticker SAN and in the United States as an ADR on Nasdaq under the ticker SNY, with the underlying ordinary share bearing ISIN FR0000120578, as stated in Sanofi investor relations materialsSanofi, 02/25/2025Nasdaq, 02/25/2025.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Sanofi Aktien ein!

<b>So schätzen die Börsenprofis  Sanofi Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | FR0000120578 | SANOFI | boerse | 69374358 |